Clinical Trials Directory

Trials / Unknown

UnknownNCT05232721

Evaluation of a Point-of-care Testing Instrument for Fecal Immunochemical Test

Status
Unknown
Phase
Study type
Observational
Enrollment
275 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Early detecting and removing of colorectal advanced adenomas can reduce incidence of colorectal cancer.Use of the fecal immunochemical test (FIT) for colorectal cancer (CRC) prevention is supported by previous studies.However existing instruments have low portability.The purpose of this study is to test the performance of a Point-of-care testing instrument for fecal Immunochemical test(FIT) .

Detailed description

Colorectal cancer (CRC) is the third most common cancer worldwide and has become a progressively important public health problem that inevitably leads to an increase in morbidity and medical costs. Therefore, many countries have a screening program in place to lower the incidence of CRC. Subjects with a positive fecal immunochemical test (FIT) have a much higher likelihood of advanced neoplasms than the general population.However existing instruments have low portability.The purpose of this study is to test the performance of a Point-of-care testing instrument for fecal immunochemical test (FIT).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThe new instrument and colonoscopy with pathological examinationDetect hemoglobin in stool by the point-of-care testing instrument before colonoscopy, detect colon lesion using colonoscopy and pathological examination.

Timeline

Start date
2022-02-20
Primary completion
2022-04-01
Completion
2022-04-20
First posted
2022-02-10
Last updated
2022-02-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05232721. Inclusion in this directory is not an endorsement.